The Burges Salmon blog

Subscribe to news and insight


Showing 25-36 of 43 results
1 2 3 4
Results per page

New Medical Practitioners Assurance Framework for Independent Healthcare Providers

The new Medical Practitioners Assurance Framework has been launched to strengthen clinical governance in the independent sector and improve the overall quality of care for patients
31 October 2019

Taxation of loyalty payments - HMRC vs Hargreaves Lansdown Asset Management

The VAT treatment of loyalty schemes has been complicated further by HMRC v Hargreaves Lansdown. We look at the legal issues and practical implications for companies and advisers

17 October 2019

Government publishes No Deal Readiness Report

Guidance from the Government issued on 8 October provides information for providers of human medicines and medical device manufacturers
08 October 2019

Press release

Burges Salmon advises Nanopharm on its acquisition by AptarGroup, Inc.

The Corporate team from Burges Salmon has acted for the shareholders of Nanopharm on its strategic acquisition by AptarGroup, Inc.
12 June 2019

Press release

Burges Salmon shortlisted for Legal Advisor of the Year at the Health Investor Awards 2019

The firm’s Healthcare team has been shortlisted for 'Legal Advisor of the Year – Private' for its work advising private sector clients in the healthcare sector.
27 February 2019

Court provides guidance on equal treatment in procurement

NHS England has been found not to have breached the principle of equal treatment in the procurement of Hepatitis C treatments.

05 February 2019

Press release

Burges Salmon healthcare team shortlisted at LaingBuisson Healthcare Awards 2018

The Burges Salmon healthcare team has been shortlisted in the annual LaingBuisson Healthcare Awards 2018 in the ‘Legal Advisor – Independent’ category.
18 October 2018

Adult social care green paper: LGA issues new consultation paper

A consultation on adult social care reform looks to stimulate debate ahead of the government’s green paper that is due to emerge in the Autumn.
16 August 2018

What makes a price excessive? The CAT weighs in on Pfizer and Flynn Pharma’s pricing

The Competition Appeal Tribunal has partially annulled the Competition and Markets Authority’s decision to fine Pfizer and Flynn Pharma for abuse of dominance by imposing excessive prices.
10 July 2018

Press release

Burges Salmon advises Jardine Lloyd Thompson Group on acquisition of Chartwell Healthcare

Burges Salmon’s corporate team advised Jardine Lloyd Thompson Group plc on its acquisition of Chartwell Healthcare to strengthen JLT’s position in the group risk and healthcare sector.
08 March 2018

Press release

Burges Salmon advises HSBC Bank on £125m credit facility

Burges Salmon advised HSBC Bank and Bank Leumi (UK) on funding for £125m revolving credit facility to Audley Group
06 February 2018

Autumn Budget 2017: health and social care bulletin

Our team looks at the key points for the health and social care sector in the Autumn 2017 Budget.
23 November 2017
Showing 25-36 of 43 results
1 2 3 4
Results per page

Events and webinars

Keep up to date with the latest legal developments. Attend an upcoming webinar or virtual event.
View all events